Italian drugmaker Chiesi to buy KalVista for $1.9 billion | 106.5 Jack FM | Playing What We Want | Kalamazoo, MI

×

Sign In

Italian drugmaker Chiesi to buy KalVista for $1.9 billion

By Thomson Reuters Apr 29, 2026 | 7:53 AM

April 29 (Reuters) – Italy’s Chiesi ‌has agreed to ‌buy KalVista ⁠Pharmaceuticals ⁠for about $1.9 billion, the ⁠company ⁠said on Wednesday, as it looks ‌to ⁠grow its rare disease ⁠drug ‌portfolio.

(Reporting ⁠by Kamal ‌Choudhury in Bengaluru; ⁠Editing by Shailesh Kuber)

Comments

Leave a Reply Cancel reply

You must be logged in to post a comment.

Cognizant forecasts quarterly revenue below estimates on cautious IT spending

Trump met with oil firms on possible months-long extension of Iran blockade

US core capital goods orders blow past expectations in March

Italian drugmaker Chiesi to buy KalVista for $1.9 billion

Brazil's Abrolhos corals, the South Atlantic's most diverse, decline as climate warms

Phillips 66 posts surprise profit on higher refining margins